Assembly BiosciencesASMB
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 30 institutions reported holding Assembly Biosciences Inc. (ASMB) in their 13F filings, up 3 from Q2 2024. 4 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($5.4M), Vanguard Group Inc. ($3.0M) and BlackRock, Inc. ($1.2M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Assembly Biosciences Inc.
- CUSIP
- 045396207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $208K |
| Exits | 1 | $41 |
All 13F filers, Q2 2024 → Q3 2024: 62,548 shares bought and 210,692 shares sold, net −148,144 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Armistice Capital, LLC | 0.14% | Reduce -24.4% | 354,000 | $5.4M |
| Vanguard Group Inc. | 0.00% | No change | 200,458 | $3.0M |
| BlackRock, Inc. | 0.00% | — | 77,108 | $1.2M |
| Renaissance Technologies | 0.00% | Add +19.5% | 65,624 | $994K |
| Acuitas Investments, LLC | 0.42% | Add +24.6% | 62,315 | $943K |
| Geode Capital Management, LLC | 0.00% | Reduce -13.6% | 47,034 | $712K |
| Millennium Management | 0.00% | Reduce -69.6% | 37,553 | $569K |
| Northern Trust Corp. | 0.00% | Add +157.8% | 29,824 | $452K |
| Federated Hermes, Inc. | 0.00% | No change | 25,394 | $384K |
| Susquehanna International Group, LLP | 0.00% | Reduce -8.9% | 15,857 | $240K |
| FMR LLC | 0.00% | Add +29.8% | 15,855 | $240K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 14,500 | $220K |
| Acadian Asset Management LLC | 0.00% | No change | 13,558 | $203K |
| State Street Corp. | 0.00% | No change | 12,809 | $194K |
| Marshall Wace, LLP | 0.00% | New | 12,725 | $193K |
| Citadel Advisors | 0.00% | Reduce -0.2% | 12,720 | $193K |
| Marquette Asset Management, LLC | 0.02% | No change | 9,016 | $137K |
| Amundi | 0.00% | No change | 7,934 | $114K |
| JPMorgan Chase & Co. | 0.00% | Add +5137.3% | 3,509 | $53K |
| Barclays PLC | 0.00% | Add +1.4% | 3,035 | $46K |
| Morgan Stanley | 0.00% | Add +3.8% | 2,660 | $40K |
| UBS Group AG | 0.00% | Reduce -55.9% | 1,301 | $20K |
| NewEdge Advisors, LLC | 0.00% | New | 762 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -24.6% | 588 | $9K |
| Bank of America Corp. | 0.00% | Add +647.8% | 344 | $5K |
| Rhumbline Advisers | 0.00% | No change | 190 | $3K |
| Osaic Holdings, Inc. | 0.00% | New | 187 | $3K |
| Lazard Asset Management LLC | 0.00% | New | 71 | $1K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 55 | $833 |
| Frazier Financial Advisors, LLC | 0.00% | No change | 1 | $16 |
"% of holder's portfolio" is ASMB's weight in each manager's 13F, not the share of Assembly Biosciences Inc. the manager owns.